nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—urethra—vaginal cancer	0.285	0.285	CbGeAlD
Tyloxapol—LPL—mammalian vulva—vaginal cancer	0.271	0.271	CbGeAlD
Tyloxapol—LPL—female reproductive system—vaginal cancer	0.232	0.232	CbGeAlD
Tyloxapol—LPL—female gonad—vaginal cancer	0.211	0.211	CbGeAlD
